AU3165777A - Derivatives of 4-phenyl 1, 4-dihydropyridine-3, 5-dicarboxylate - Google Patents

Derivatives of 4-phenyl 1, 4-dihydropyridine-3, 5-dicarboxylate

Info

Publication number
AU3165777A
AU3165777A AU31657/77A AU3165777A AU3165777A AU 3165777 A AU3165777 A AU 3165777A AU 31657/77 A AU31657/77 A AU 31657/77A AU 3165777 A AU3165777 A AU 3165777A AU 3165777 A AU3165777 A AU 3165777A
Authority
AU
Australia
Prior art keywords
dihydropyridine
dicarboxylate
phenyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU31657/77A
Other versions
AU518206B2 (en
Inventor
Y Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU3165777A publication Critical patent/AU3165777A/en
Application granted granted Critical
Publication of AU518206B2 publication Critical patent/AU518206B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
AU31657/77A 1976-12-17 1977-12-16 Derivatives of 4-phenyl 1, 4-dihydropyridine-3, 5-dicarboxylate Expired AU518206B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB52720/76 1976-12-17
GB52720/76A GB1591089A (en) 1976-12-17 1976-12-17 1,4-dihydropyridine derivatives and process for preparation thereof

Publications (2)

Publication Number Publication Date
AU3165777A true AU3165777A (en) 1979-06-21
AU518206B2 AU518206B2 (en) 1981-09-17

Family

ID=10465031

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31657/77A Expired AU518206B2 (en) 1976-12-17 1977-12-16 Derivatives of 4-phenyl 1, 4-dihydropyridine-3, 5-dicarboxylate

Country Status (15)

Country Link
JP (1) JPS5948828B2 (en)
AR (2) AR221478A1 (en)
AT (1) AT367401B (en)
AU (1) AU518206B2 (en)
BE (1) BE861964A (en)
CH (1) CH633266A5 (en)
DE (1) DE2756226A1 (en)
DK (2) DK563377A (en)
ES (3) ES465137A1 (en)
FR (1) FR2374307A1 (en)
GB (1) GB1591089A (en)
HU (1) HU176454B (en)
NL (1) NL7714066A (en)
SE (2) SE7714374L (en)
ZA (1) ZA777532B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610753B2 (en) * 1986-04-02 1991-05-23 Fournier Industrie Et Sante Asymmetrical ester derivatives of 1,4-dihydropyridine-3, 5-dicarboxylic acid

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE2935451A1 (en) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE3018259A1 (en) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-DIHYDROPYRIDINE WITH DIFFERENT SUBSTITUENTS IN 2- AND 6-POSITIONS, METHODS FOR THEIR PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
JPS57175164A (en) * 1981-04-18 1982-10-28 Banyu Pharmaceut Co Ltd 1,4-dihydropyridine derivative and its preparation
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
FI862343A (en) 1985-06-17 1986-12-18 Warner Lambert Co FRAME FOR THE PREPARATION OF THERAPEUTIC NETWORK 1,4-DIHYDROPYRIDIN INFOERING.
EP0226271B1 (en) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-dihydropyridine compounds and their preparation and pharmaceutical formulation
DE3544211A1 (en) * 1985-12-13 1987-06-19 Bayer Ag NEW, FLUORINE 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
IT1204460B (en) * 1986-02-20 1989-03-01 Glaxo Spa HETEROCYCLIC DERIVATIVES
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
JPS63115890A (en) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd 2-substituted 1,4-dihydropyridine derivative
US5977369A (en) * 1995-12-28 1999-11-02 Napp Technologies, Inc. Process to prepare dihydropyridine and derivatives thereof
CN103951608B (en) * 2009-08-04 2016-04-27 喜德生（苏州）医药科技有限公司 Nilvadipine crystal formation and preparation method thereof
CN103254122B (en) * 2013-06-19 2015-04-22 湖南师范大学 Preparation method of cardiovascular drug nilvadipine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (en) * 1969-12-17 1971-06-24 Bayer Ag New cyanophenyl-1,4-dihydropyridine derivatives
DE2248150A1 (en) * 1972-09-30 1974-04-04 Bayer Ag DIHYDROPYRIDINE POLYESTER, METHOD FOR MANUFACTURING AND USING THEM AS A MEDICINAL PRODUCT
US3946027A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US3946028A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-4-pyridyl-1,4-dihydropyridine derivatives
DE2335466A1 (en) * 1973-07-12 1975-01-30 Bayer Ag ALCOXY ALKYL-1,4-DIHYDROPYRIDINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT
CH607848A5 (en) * 1974-06-04 1978-11-30 Bayer Ag
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610753B2 (en) * 1986-04-02 1991-05-23 Fournier Industrie Et Sante Asymmetrical ester derivatives of 1,4-dihydropyridine-3, 5-dicarboxylic acid

Also Published As

Publication number Publication date
DK172182A (en) 1982-04-16
ES465137A1 (en) 1979-01-01
DK563377A (en) 1978-06-18
SE8204312D0 (en) 1982-07-13
FR2374307A1 (en) 1978-07-13
GB1591089A (en) 1981-06-10
DE2756226A1 (en) 1978-06-29
FR2374307B1 (en) 1981-02-13
AT367401B (en) 1982-07-12
SE7714374L (en) 1978-06-18
HU176454B (en) 1981-03-28
BE861964A (en) 1978-06-16
ZA777532B (en) 1978-10-25
SE8204312L (en) 1982-07-13
AU518206B2 (en) 1981-09-17
ES474233A1 (en) 1979-11-01
AR221478A1 (en) 1981-02-13
CH633266A5 (en) 1982-11-30
JPS5948828B2 (en) 1984-11-29
NL7714066A (en) 1978-06-20
JPS5395977A (en) 1978-08-22
AR221887A1 (en) 1981-03-31
ATA901877A (en) 1981-11-15
ES474234A1 (en) 1979-04-01

Similar Documents

Publication Publication Date Title
AU510353B2 (en) 1, 4-dihydro-pyridine derivatives
AU518206B2 (en) Derivatives of 4-phenyl 1, 4-dihydropyridine-3, 5-dicarboxylate
AU536055B2 (en) Derivatives of 1,4 dihydropyridine substituted by benzoxadiazole or benzthiadiazole
AU514452B2 (en) 3, 3, 3-triarylalkyl-4-phenylalkl-4-hydroxy piperidine derivatives
AU517830B2 (en) Piperidine derivatives
AU508171B2 (en) 4 hydroxy-aporphine derivatives
AU508738B2 (en) 8-oxo-3-oxa-l-azabicycio [4,2,0] - cotane derivatives
AU3210377A (en) 1, 4-dihydropyridine derivatives
AU506432B2 (en) 4 ((4 Diphenylmethyl) l-piperidinyl)methyl) benzenamines
AU508791B2 (en) Indazolyl-(4)-oxypropanolamine derivatives
AU506052B2 (en) Preparation of 2-(2, 2-dicyclohexylethyl) piperidine
AU515506B2 (en) 1, 2, 4-oxadiazole derivatives
AU503926B2 (en) 1, 3-BENZODITHIOLE-2-ONE (and 2-THIONIC) DERIVATIVES
AU511784B2 (en) Seldomycin factor 5 derivatives
AU522759B2 (en) 4-phenyl-thieno-[2, 3-c]-piperidine derivatives
AU505161B2 (en) 1, 3, 5, 7-tetraaza-4-sulpha-hept-1-en-6-one derivatives
AU510764B2 (en) Preparation of 2, 3-Dichloroanisole
AU511156B2 (en) 7, 7-Dimethylnorbornane derivatives
AU505183B2 (en) Preparation of 2(2, 2 dicyclohexylethyl) piperidine
AU5759080A (en) Dihydropyridine derivatives
AU513066B2 (en) 3 amino-2hydroxy-propoxphenyl derivatives
ZA773350B (en) New 1-substituted derivatives of 2,2-diphenylcyclopropane
AU493335B2 (en) Piperidine derivatives
AU490730B2 (en) 5(6)-pyridazin-6-yl-benzimidazole derivatives
AU515307B2 (en) 1, 3-benzodioxine derivatives